Jung-min Ahn
Quick facts
Marketed products
- Aspirin only
- High-intensity statin · Cardiovascular
High-intensity statins inhibit HMG-CoA reductase to potently reduce LDL cholesterol synthesis in the liver. - No antiplatelet therapy
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Jung-min Ahn
What are Jung-min Ahn's marketed drugs?
Top marketed products include Aspirin only, High-intensity statin, No antiplatelet therapy.
Related
- Aspirin only
- High-intensity statin · Cardiovascular
- No antiplatelet therapy
- Sector hub: All tracked pharma companies